Another crazed, gun-toting kid wantonly, tragically kills ten and wounds three innocent people

in a small upstate New York town. We’ve heard this scenario played out time and again. Is it

really that simple? Another crazy kid spewing hate, remedying his discontent in a hail of bullets.

Maybe.But why not conduct a complete investigation, including releasing the shooter’s psychiatric

drug “treatment?”

Law enforcement, lawmakers and media pundits whip out the same tired script, focusing on the

killing weapon…the gun, while completely ignoring another possibility for the murderous

madness – mental health psychiatric drug “treatment.” How many more must die before an

open, honest, dialogue takes place about the serious adverse events associated with mental

health “treatment?”

What is known so far is that Payton Gendron, 18, has a mental health history. How far back this

history goes may never be released. But we do know that he was investigated in 2021 just prior

to his graduation from High School for making what then were taken as threatening comments

to classmates.

The then 17-year-old, reported by school officials, was taken into custody by the New York

state police and admitted for a mental health evaluation. The 17-year-old was evaluated for

about a day and a half and released. Police Commissioner, Joseph Gramaglia, did not describe

the findings of the mental health evaluation nor what, if any, drug “treatment” was provided.


Certainly, authorities can’t be falling back on the privacy protections provided under the HIPPA.

Those privacy protections effectively went out the window with the COVID-19 pandemic. The

minute the emergency vaccines were instituted, health privacy meant nothing when

government entities decided that the health and welfare of all far outweighed the privacy of a


Where does this deliberate refusal to release the mental health history, including all prescribed

psychiatric medications, come from? Is it really about protecting the medical records of the

accused shooter or, perhaps, is it really about protecting the mental health regime and

pharmaceutical giants from failed diagnoses and murderous treatments?

What, exactly, was the result of Gendron’s mental health examination? Was Gendron provided

a psychiatric diagnosis and “treated” with psychotropic (mind-altering) drugs? Was Gendron

requested to attend mental health anger management classes? Was there follow up after the

evaluation, which included his parents ensuring their son was taking his drug “treatment?” No

one knows and it appears that the authorities don’t seem to think that it matters. But it does


Take for instance, that it is not widely known that despite a litany of antidepressants on the market, only

Prozac has been approved by the Food and Drug Administration (FDA) for use in children. All other

antidepressants are prescribed by doctors “off-label” to children. According to the adverse events listed by

the drug companies, antidepressants can cause the following adverse effects: Mania, Psychosis, Abnormal

Behavior, Anxiety, Violent Behavior, depersonalization, hallucinations, hostility, and delusions to name a

few, and come with an FDA Black Box Warning for causing Suicidality – the FDA’s most serious warning

before removing a drug from the market.

Given the adverse events listed above, would not the public be better served if it knew less

about the make and model of the killing weapon and more about the shooter’s possible

psychiatric drug use and mental health status? One could argue that it couldn’t hurt to know all

the information about these shooters…something along the lines of informed consent.

Ablechild, perhaps, came very close to getting the reasoning behind law enforcement and

lawmakers’ reluctance to release mental health “treatment” data. During a 2013 Freedom of

Information Act (FOIA) Hearing – Ablechild vs. Chief Medical Examiner

which was seeking information about Sandy Hook shooter, Adam Lanza’s mental health records, the

attorney for the Office of the Attorney General, Patrick Kwanashie, argued that release of Adam

Lanza’s records to the public “can cause a lot of people to stop taking their medications.” Bingo!

More frightening to the pharmaceutical industry and mental health regime, though, is that one

might also argue that if the mental health drug “treatment” information of all shooters was

made available to the public, maybe people wouldn’t take the psychiatric drugs at all…ever.

The documentation supporting a connection between school shootings and/or school-related

acts of violence and those taking or withdrawing from psychiatric drugs, resulting in 162

wounded and 72 killed, is readily available.

Unfortunately, while the information, if made available, won’t bring back those so wrongfully

harmed by the brutal actions of these shooters, but having the mental health data and drug

“treatments” prescribed to them may lead to a better understanding of the role psychiatric

drugs may play in these shootings.

Maybe. Just maybe. If parents are made aware of the possible adverse events associated with

the psychiatric “treatments,” and if they are made aware that too many of the shooting

incidents that occur are carried out by those who are on or are withdrawing from psychiatric

drug use, maybe they may opt for, even insist upon, a different treatment plan.

It’s time to consider that there is more to these random crazed kid shooters. Afterall, there

seems little doubt if the shooter had been on an illegal substance, such as Fentanyl or Meth,

authorities would have released that information to the public. Why, then, are the prescribed

psychiatric mind-altering drugs used as “treatment” given a protected status?

The answer may be very frightening to the mental health industry. Maybe. Just maybe, mental

health “treatments” don’t work and sometimes they may actually put the public at risk of great

bodily harm. If the powers that be really want to end this senseless violence, they have to start

asking the right questions and providing the public with all the information.